New Frontiers In Functional Medicine

Fatty acids remain one of the most debated areas in clinical nutrition, yet many widely held beliefs may not align with current evidence. In this episode of New Frontiers in Functional Medicine, Dr. Kara Fitzgerald sits down with Bill Harris, PhD, Founder of OmegaQuant Analytics and co-inventor of the Omega-3 Index, to examine the role of omega-3 and omega-6 fatty acids in cardiovascular risk and clinical decision-making. Learn how to use the Omega-3 Index as a biomarker, interpret atrial fibrillation risk in the context of omega-3 intake, and differentiate between pharmaceutical and dietary interventions. The conversation also explores emerging data on linoleic acid, challenges simplified “good vs bad fat” models, and highlights the complexity of fatty acid metabolism—offering practical guidance for evaluating labs and refining nutrition strategies in practice. Full show notes + references: https://www.drkarafitzgerald.com/fxmed-podcast/ GUEST DETAILS Dr. Bill Harris, PhD is a leading omega-3 researcher